Upper airway · 1: Allergic rhinitis and asthma: United disease through epithelial cells

Thorax

Volumn 64, Issue 11, 2009, Pages 999-1004

  Bourdin, A ^a   Gras, D ^b   Vachier, I ^a   Chanez, P ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID DERIVATIVE; ANTIINFLAMMATORY AGENT;

ALLERGIC RHINITIS; ASTHMA; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CD8+ T LYMPHOCYTE; CELL FUNCTION; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EOSINOPHIL COUNT; EPITHELIUM CELL; HUMAN; IMMUNOREACTIVITY; MUCUS SECRETION; NASAL BIOPSY; NOSE MUCOSA; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHINITIS; RHINOSINUSITIS; BRONCHUS; IMMUNOLOGY; NOSE; PATHOLOGY; SINUSITIS;

ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHI; COMORBIDITY; EPITHELIAL CELLS; HUMANS; NOSE; RHINITIS; SINUSITIS;

EID: 72549101807     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.112862     Document Type: Review

References (66)

1. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003;111:1171-1184 (Pubitemid 36683664)
2. Chanez P. Severe asthma is an epithelial disease. Eur Respir J 2005;25:945-946
3. Demoly P, Bousquet J. The relation between asthma and allergic rhinitis. Lancet 2006;368:711-713
4. Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419-425 (Pubitemid 34234190)
5. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372:1049-1057
6. Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301-304 (Pubitemid 29420424)
7. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001;164:858-865
8. Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107:469-476
9. Lipworth BJ, White PS. Allergic inflammation in the unified airway: start with the nose. Thorax 2000;55:878-881 (Pubitemid 30744225)
10. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-178
11. Chanez P, Wenzel SE, Anderson GP, et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol 2007;119:1337-1348
12. Bresciani M, Paradis L, Des Roches A, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol 2001;107:73-80.
13. ten Brinke A, Grootendorst DC, Schmidt JT, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002;109:621-626
14. Bousquet PJ, Bousquet-Rouanet L, Co Minh HB, et al. ARIA (Allergic Rhinitis and its Impact on Asthma) classification of allergic rhinitis severity in clinical practice in France. Int Arch Allergy Immunol 2007;143:163-169 (Pubitemid 46918457)
15. Passalacqua G, Bousquet PJ, Carlsen KH, et al. ARIA update: I - Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol 2006;117:1054-1062
16. Vachier I, Vignola AM, Chiappara G, et al. Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax 2004;59:303-307 (Pubitemid 38496747)
17. Raherison C, Montaudon M, Stoll D, et al. How should nasal symptoms be investigated in asthma? A comparison of radiologic and endoscopic findings. Allergy 2004;59:821-826
18. Carr WW, Nelson MR, Hadley JA. Managing rhinitis: strategies for improved patient outcomes. Allergy Asthma Proc 2008;29:349-357
19. van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116-134 (Pubitemid 30106016)
20. Bachert C, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the Workshop Report. 7-10 December 1999, Geneva, Switzerland. Allergy 2002;57:841-855
21. Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002;57:309-316 (Pubitemid 34298927)
22. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-705 (Pubitemid 24275742)
23. Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002;109:636-642 (Pubitemid 34327190)
24. Bousquet J, Gaugris S, Kocevar VS, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy (corrected). Clin Exp Allergy 2005;35:723-727
25. Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109:57-62. (Pubitemid 34112130)
26. de Benedictis FM, del Giudice MM, Severini S, et al. Rhinitis, sinusitis and asthma: one linked airway disease. Paediatr Respir Rev 2001;2:358-364 (Pubitemid 34467153)
27. Polosa R, Prosperini G, Tomaselli V, et al. Expression of c-erbB receptors and ligands in human nasal epithelium. J Allergy Clin Immunol 2000;106:1124-1131 (Pubitemid 32006267)
28. Shaida A, Kenyon G, Devalia J, et al. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 2001;108:791-796 (Pubitemid 33096212)
29. Chanez P, Vignola AM, Vic P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999;159:588-595 (Pubitemid 29084885)
30. Gaga M, Lambrou P, Papageorgiou N, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000;30:663-669
31. Crystal RG, Randell SH, Engelhardt JF, et al. Airway epithelial cells: current concepts and challenges. Proc Am Thorac Soc 2008;5:772-777
32. Churg A. The uptake of mineral particles by pulmonary epithelial cells. Am J Respir Crit Care Med 1996;154:1124-1140
33. Sparrow MP, Omari TI, Mitchell HW. The epithelial barrier and airway responsiveness. Can J Physiol Pharmacol 1995;73:180-190
34. Ciprandi G, Pronzato C, Ricca V, et al. Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure. J Allergy Clin Immunol 1994;94:738-746
35. Howarth PH, Salagean M, Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy 2000;55(Suppl 64):7-16.
36. Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17:683-690
37. Nilsson G, Hjertson M, Andersson M, et al. Demonstration of mast-cell chemotactic activity in nasal lavage fluid: characterization of one chemotaxin as c-kit ligand, stem cell factor. Allergy 1998;53:874-879
38. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 2004;23:327-333
39. Martinez-Anton A, Debolos C, Garrido M, et al. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa. Clin Exp Allergy 2006;36:448-457
40. Shimura S, Andoh Y, Haraguchi M, et al. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996;9:1395-1401
41. Kondo M, Tamaoki J, Takeyama K, et al. Elimination of IL-13 reverses established goblet cell metaplasia into ciliated epithelia in airway epithelial cell culture. Allergol Int 2006;55:329-336
42. Kondo M, Tamaoki J, Takeyama K, et al. Interleukin-13 induces goblet cell differentiation in primary cell culture from Guinea pig tracheal epithelium. Am J Respir Cell Mol Biol 2002;27:536-541
43. Lordan JL, Bucchieri F, Richter A, et al. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol 2002;169:407-414
44. Deshmukh HS, Case LM, Wesselkamper SC, et al. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am J Respir Crit Care Med 2005;171:305-314
45. Shao MX, Nadel JA. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci U S A 2005;102:767-772
46. Fahy JV. Goblet cell and mucin gene abnormalities in asthma. Chest 2002;122(6 Suppl):320-6S.
47. Chu HW, Balzar S, Seedorf GJ, et al. Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma. Am J Pathol 2004;165:1097-1106
48. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006;86:245-278
49. Rousseau K, Byrne C, Griesinger G, et al. Allelic association and recombination hotspots in the mucin gene (MUC) complex on chromosome 11p15.5. Ann Hum Genet 2007;71:561-569 (Pubitemid 47087064)
50. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007;120:1233-1236
51. Bresciani M, Laliberte F, Laliberte MF, et al. Nerve growth factor localization in the nasal mucosa of patients with persistent allergic rhinitis. Allergy 2009;64:112-117
52. Olgart Hoglund C, de Blay F, Oster JP, et al. Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J 2002;20:1110-1116 (Pubitemid 35331866)
53. Shahana S, Jaunmuktane Z, Asplund MS, et al. Ultrastructural investigation of epithelial damage in asthmatic and non-asthmatic nasal polyps. Respir Med 2006;100:2018-2028 (Pubitemid 44490278)
54. Bayram H, Rusznak C, Khair OA, et al. Effect of ozone and nitrogen dioxide on the permeability of bronchial epithelial cell cultures of non-asthmatic and asthmatic subjects. Clin Exp Allergy 2002;32:1285-1292 (Pubitemid 35024953)
55. Bucchieri F, Puddicombe SM, Lordan JL, et al. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol 2002;27:179-185 (Pubitemid 34780797)
56. Holgate ST, Holloway J, Wilson S, et al. Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc 2004;1:93-98
57. Amishima M, Munakata M, Nasuhara Y, et al. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med 1998;157:1907-1912
58. Puddicombe SM, Polosa R, Richter A, et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. Faseb J 2000;14:1362-1374 (Pubitemid 30439745)
59. Mullings RE, Wilson SJ, Puddicombe SM, et al. Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol 2001;108:832-838
60. Sampath D, Castro M, Look DC, et al. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J Clin Invest 1999;103:1353-1361 (Pubitemid 29218306)
61. Holgate ST, Lackie P, Wilson S, et al. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. Am J Respir Crit Care Med 2000;162:S113-7. (Pubitemid 30707966)
62. Foresi A, Leone C, Pelucchi A, et al. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J Allergy Clin Immunol 1997;100:58-64. (Pubitemid 27328532)
63. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005;73:141-162
64. Bonnans C, Fukunaga K, Levy MA, et al. Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am J Pathol 2006;168:1064-1072
65. Chiang N, Arita M, Serhan CN. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fatty Acids 2005;73:163-177 (Pubitemid 41253473)
66. Bonnans C, Gras D, Chavis C, et al. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells. Biomed Pharmacother 2007;61:261-267 (Pubitemid 46891725)